Brief: Talaris Therapeutics Announces Q3 Financial Results
Nov 10 (Reuters) - Talaris Therapeutics Inc TALS.O :
* TALARIS THERAPEUTICS ANNOUNCES THIRD QUARTER FINANCIAL
RESULTS
AND CORPORATE UPDATE
* TALARIS THERAPEUTICS INC Q3 LOSS PER SHARE $0.46
* TALARIS THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.46
Source text for Eikon: ID:nGNX3FppCX
Further company coverage: TALS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tourmaline Bio
See all newsBrief: Novartis Completes Acquisition Of Tourmaline Bio
Brief: Novartis Announces Expiration Of Tourmaline Bio Tender Offer
Novartis nears deal to acquire Avidity Biosciences for over $70 per share, Bloomberg News reports (updated)
Brief: Novartis Announces Commencement Of Tender Offer To Acquire Tourmaline Bio
U.S. STOCKS ON THE MOVE-Potbelly, Joby, Talen Energy